The diagnostic value of combined detection of microRNA-155, TNF-α and IL-37 for active pulmonary tuberculosis in the

Longmei Yu1, Haiyang Fu1, Haiyun Zhang1

  • 1Department of Laboratory Medicine, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) Nantong 226001, Jiangsu, P. R. China.

Abstract

Insights

Biomarkers microRNA-155 (miR-155), tumor necrosis factor-alpha (TNF-α), and interleukin-37 (IL-37) show promise for diagnosing active pulmonary tuberculosis (PTB) in elderly individuals. Their combined detection in serum offers a potential new diagnostic tool for active PTB in this population.

Area of Science:

  • Biochemistry
  • Immunology
  • Geriatrics

Background:

  • Active pulmonary tuberculosis (PTB) poses diagnostic challenges, particularly in elderly populations.
  • Identifying reliable biomarkers is crucial for early and accurate PTB diagnosis in older adults.

Purpose of the Study:

  • To evaluate microRNA-155 (miR-155), tumor necrosis factor-alpha (TNF-α), and interleukin-37 (IL-37) as potential serum biomarkers for active PTB diagnosis in the elderly.
  • To assess the diagnostic performance of these biomarkers, individually and in combination.

Main Methods:

  • Serum levels of miR-155 and TNF-α were measured using RT-qPCR.
  • Serum IL-37 levels were determined by ELISA.
  • Receiver operating characteristic (ROC) curves were used to calculate AUCs and assess sensitivity and specificity.

Main Results:

  • miR-155, TNF-α, and IL-37 were significantly overexpressed in the sera of elderly patients with active PTB.
  • Higher serum levels correlated with more extensive disease (pulmonary and extrapulmonary TB, bilateral lung involvement).
  • The combination of these three biomarkers demonstrated improved diagnostic sensitivity (84.78%).

Conclusions:

  • Serum miR-155, TNF-α, and IL-37 are elevated in elderly patients with active PTB.
  • The combined detection of these biomarkers presents a promising diagnostic strategy for active PTB in the elderly population.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
409
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
295
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K